Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
Conditions: Heart Failure With Reduced Ejection Fraction Interventions: Device: Atrial pacing with respiratory sinus arrhythmia (RSA) variability; Device: Monotonic right atrial overdrive pacing Sponsors: Ceryx Medical Australia; Avania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients
Conditions: Heart Failure With Reduced Ejection Fraction Interventions: Drug: Renin-Angiotensin System Inhibitor Sponsors: Chulalongkorn University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure
Conditions: Heart Failure Interventions: Other: Interdisciplinary decision-making for perioperative care Sponsors: University of Giessen; Deutsche Luft und Raumfahrt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events
Conditions: COPD Exacerbation; COPD; Cardio/Pulm: Heart Failure Interventions: Other: NuvoAir clinical service Sponsors: NuvoAir Medical PC; Optum, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction; Prognathism Sponsors: Chongqing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Clinical and Therapeutic Characteristics of Geriatric Patients Hospitalized for Heart Failure (AGING HF Study (AGe and Heart Failure IN Geriatrics))
Conditions: Patients Hospitalized in Geriatrics for Heart Failure; Patients Aged 75 and Over Sponsors: G érond ' if Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Decision Support System for Diagnosis and Progression of Heart Failure
Conditions: Heart Failure Interventions: Diagnostic Test: Cardiac Output Response to Stress (CORS) test Sponsors: Coventry University; Newcastle University; University of Cambridge; University of Novi Sad; University of Florence; University of Regensburg; Utrecht University; Servicio Madrile ño de Salud, Madrid, Spain Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Study on Heart Failure With Preserved Ejection Fraction With Qishen Granules
Conditions: Heart Failure With Preserved Ejection Fraction Interventions: Drug: Qishen Granules; Drug: Placebo Sponsors: Guangdong Provincial Hospital of Traditional Chinese Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
An international, observational, blinded study to assess the performance of the cordio hearo system
Conditions: Heart Failure Interventions: Device: Hearo App Sponsors: Cordio Medical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure
Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024– Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 18, 2024 Category: Pharmaceuticals Source Type: clinical trials
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Conditions: Diabetes; Hypertension; High Cholesterol/Hyperlipidemia; Coronary Artery Disease; Congestive Heart Failure; Chronic Lung Disease; Chronic Kidney Diseases; Arrythmia; Stroke; Depression; Anxiety; Pulmonary Embolism; Heart Attack Interventions: Other: Med AAAction intervention Sponsors: University of Tennessee; Sponsor GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure
Conditions: End-stage Renal Disease Interventions: Procedure: Lung and inferior vena cava ultrasound guidance; Procedure: Conventional protocol guidance Sponsors: The First Affiliated Hospital with Nanjing Medical University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Ipsc biobaNk oF biomarkERs divErsity iN Cardiovascular disEase
Conditions: Cardiovascular Diseases; Arrythmia; Cardiomyopathies; Heart Failure; Cerebrovascular Accident; Congenital Heart Disease; Cardiometabolic Syndrome Sponsors: Lawson Health Research Institute; Greenstone Biosciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Study of JK07 in Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction; Heart Failure With Preserved Ejection Fraction Interventions: Drug: JK07; Drug: Placebo Sponsors: Salubris Biotherapeutics Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Phase 2 Study of JK07 in Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction; Heart Failure With Preserved Ejection Fraction Interventions: Drug: JK07; Drug: Placebo Sponsors: Salubris Biotherapeutics Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
